Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-02-22 (endpts.com)
Bourla praises Trump as RFK Jr. preps vaccine review; Will CRISPR matter? ; Atomwise hires new CEO; and more
Pfizer CEO Albert Bourla supports Trump administration at PhRMA Forum, while CDC postpones vaccine advisory meeting. Atomwise names Steve Worland as CEO, and Biogen licenses Dravet drug.
Read more
2025-02-03 (panoramafarmaceutico.com.br)
Biogen has a new HEAD of Human Resources
Priscila Damiani is the new HEAD of Human Resources for Brazil in Biogen, a multinational pharmacist of American origin. With 26 years of experience, the
Read more
2025-01-27 (stocktitan.net)
Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal
Sage's Board unanimously rejects Biogen's $7.22/share offer as undervalued, initiates comprehensive strategic review while maintaining focus on ZURZUVAE's PPD market growth.
Read more
2025-01-27 (biospace.com)
Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal -
Company Board Concludes the Proposal Significantly Undervalues Sage and Believes it is Not in the Best Interest of Shareholders
Read more
2025-01-24 (statnews.com)
Biogen CEO tells Mass. governor he’s concerned about ‘a lot more policy risk’ in D.C.
Biogen CEO told Massachusetts Gov. Maura Healey this week he’s concerned about "a lot more policy risk" in D.C.
Read more
2025-01-21 (newtelegraphng.com)
HBI Names CA -
ShareA translational biomedical research hub in Nigeria, Helix Biogen Institute (HBI) has appointed Emmanuel Adediran as country ambassador to the United States. This prestigious role highlights his commitment to advancing vaccine development and his impactful contributions to global health. Adediran, a distinguished Nigerian trained pharmacist and scholar in pharmaceutical sciences will serve as a key...
Read more
2025-01-16 (investing.com)
Biogen appoints new Chief Accounting Officer By
Biogen Inc. (NASDAQ: ), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025. The announcement, based on a recent SEC filing, indicates a strategic shift in the company's finance leadership as current Chief Financial Officer Michael McDonnell is set to retire on the same date.
Read more
2025-01-15 (chosun.com)
Biogen CEO targets faster dementia treatment launch with new subcutaneous Leqembi option -
Biogen CEO targets faster dementia treatment launch with new subcutaneous Leqembi option Biogens CEO sees potential for efficient at-home dementia tre
Read more
2025-01-12 (statnews.com)
Biogen CEO is shopping for biotechs: ‘We will be doing deals’ |
Biogen is looking to augment growth by hunting for biotechs with drugs in mid- and late-stage clinical development.
Read more
2025-01-10 (pharmiweb.com)
Biogen Appoints Adam Feire as Head of Business Development and External Innovation -
Biogen Inc. (Nasdaq: BIIB) – today announced the appointment of Adam Feire, Ph.D., as Head of Business Development and External Innovation. Mr. Feire reports to Adam Keeney, Ph.D., Executive Vice President and Head of Corporate Development. In this role, Mr. Feire leads the search and evaluation of external ...
Read more
2024-11-10 (forex.ca)
Biogen CEO to leave as Alzheimer’s drug struggles By Reuters
© Reuters. Biogen logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration (Reuters) – Biogen (NASDAQ:
Read more
2024-10-30 (medwatch.dk)
Biogen gets a new medical director
The American pharmaceutical company has raided Bristol-Myers Squibb and brought in Daniel Quirk, who will become Biogen's medical director and head of medical affairs.
Read more